Janssen Cilag S.A.S.: Clinical Trials

4 completed, 3 recruiting, 2 terminated. 2 Phase 4, 1 Not applicable, 1 Phase 1, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 4	2	Terminated 2
Not applicable	1	Recruiting 1
Phase 1	1	Completed 1
Phase 3	1	Completed 1

Follow Janssen Cilag S.A.S.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France Prostatic Neoplasms, Metastatic Hormone-sensitive Prostate Cancer		Recruiting	Janssen Cilag S.A.S.	540	2025-12-18	2026-09-25
Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD) adapted physical activity - Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)	Not applicable	Recruiting	Raincy Montfermeil Hospital Group	72	2025-09-15	2025-09-24
Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia Individual Physical Activity Intervention (IPAI), Ibrutinib - Leukemia, Lymphocytic, Chronic, B-Cell		Recruiting	Janssen Cilag S.A.S.	180	2024-05-27	2026-09-25
Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases Ustekinumab - Crohn Disease, Colitis, Ulcerative		Completed	Janssen Cilag S.A.S.	111	2018-09-26	2025-04-27
A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab Ustekinumab - Psoriatic Arthritis		Completed	Janssen Cilag S.A.S.	221	2017-04-25	2025-02-03
Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of Clopidogrel Treatment A - rabeprazole, Treatment B - omeprazole, Treatment C - placebo - Healthy	Phase 1	Completed	Janssen Cilag S.A.S.	39	2009-11-01	2012-09-21
Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study) Epo-alpha - Resuscitation, Cardiopulmonary	Phase 3	Completed	Janssen Cilag S.A.S.	20	2003-11-01	2011-05-17
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain fentanyl - Pain	Phase 4	Terminated	Janssen Cilag S.A.S.	34	2003-06-01	2011-05-17
Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency Epoetin alfa - Anemia, Renal Failure, Chronic Renal Failure	Phase 4	Terminated	Janssen Cilag S.A.S.	217	2001-02-01	2011-05-17

Conditions studied

Colitis, Ulcerative (2)  ·  Agnosia (1)  ·  Anemia (1)  ·  Arthritis, Psoriatic (1)  ·  Cancer Pain (1)  ·  Crohn Disease (1)  ·  Heart Arrest (1)  ·  Inflammatory Bowel Diseases (1)  ·  Kidney Failure, Chronic (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Pain (1)  ·  Prostatic Neoplasms (1)

Interventions

Ustekinumab (2)  ·  Epoetin Alfa (1)  ·  Fentanyl (1)  ·  ibrutinib (1)

Countries

France (5)

Results publications

PMID 18037223, PMID 21560190, PMID 27914655, PMID 27914657, PMID 36791280, PMID 39478988

NIH funding

2009 (1)